Kallikrein 13 anticorps (AA 262-277)

N° du produit ABIN289487

Détail du produit anti-Kallikrein 13 anticorps

Antigène: Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))

Épitope: AA 262-277

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Kallikrein 13 est non-conjugé

Application: Western Blotting (WB)

Purification: Affinity chromatography purified

Immunogène: KLK-L4 antibody was raised in rabbit using AA 262-277 [IRKYETQQQKWLKGPQ] of the human KLK-L4 protein as the immunogen.

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: Lot specific

Buffer: Affinity purified IgG supplied in PBS with 0.02 % NaN3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

Détails sur Kallikrein 13

Antigène: Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))

Autre désignation: KLK-L4 (KLK13 Produits)

Synonymes: anticorps KLK-L4, anticorps KLKL4, anticorps Egfbp-2, anticorps mGk-13, anticorps kallikrein related peptidase 13, anticorps kallikrein related-peptidase 13, anticorps KLK13, anticorps Klk13

Sujet: Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. The novel KLK gene, KLK-L4, is expressed in a variety of tissues including prostate, salivary gland, breast, and testis. Its expression is regulated by steroid hormones in breast cancer cell lines may be involved in the pathogenesis and/or progression of breast cancer.

Pathways: Système du Complément